Grigoris Karamasis (@grkaramasis) header
Grigoris Karamasis (@grkaramasis) profile picture

Interventional Cardiologist, Attikon University Hospital

Athens, Greece
Joined January 2010
Photo by Grigoris Karamasis (@grkaramasis)Photo by Grigoris Karamasis (@grkaramasis)Photo by Grigoris Karamasis (@grkaramasis)
Grigoris Karamasis retweeted
ORBITA-CTO will be presented in... 55 minutes time. #Acc26 @EssexCTC – at New Orleans, LA
2
8
425
Grigoris Karamasis retweeted
A superb educational live case of bolus and continuous thermodilution and spasm provocation - congratulations @Dizzledavies73 @kliokon @MSEResearchTeam @EssexCTC @EssexCTC_Cardio @MSEssex_ICS
We’re live from the Essex Cardiothoracic Centre 🇬🇧 Drs John Davies and Klio Konstantinou demonstrate how today's concepts translate into action at the table. @CoreAalst
8
15
1,677
Intracoronary Imaging and Physiology Course 2025 Edition, 15th February 2025, Stavros Niarchos Foundation Cultural Centre, Athens, Greece 1-day course on Intracoronary Imaging and Physiology featuring case-based discussion, expert lectures, cases-in-a-box and hands-on workshops.
115
Grigoris Karamasis retweeted
It's a lovely review @JEscaned . Proud that the last 5 manuscripts included are all from our @EssexCTC @MSEResearchTeam clinical trial with Eindhoven and Brighton. ORBITA CTO pilot study coming soon....@Dizzledavies73 @dr_skhan1 @rallamee
How does the presence of a CTO influence coronary physiology measurements in other vessels? What time-dependent physiological changes take place after successful CTO PCI? All this discussed in the article published today in @MyJSCAI Open access here: shorturl.at/PdbXq
2
15
1,141
Grigoris Karamasis retweeted
Accuracy of PW–Derived Indices in LMCA Disease @JACCJournals 🔗 authors.elsevier.com/a/1kPI1… ➡️FFR superior to NHPRs at detecting significant LMCA disease ➡️Discordance rates: iFR 18.1% and Pd/Pa 17.0%, primarily due to false negatives @TheBHF @kingscardio @PCRonline @ACCinTouch
3
18
2
53
10,048
Grigoris Karamasis retweeted
In LMCA Disease FFR is superior to NHPRs at detecting significant LMCA disease Clinically significant discordance with NHPRs 🔗 authors.elsevier.com/a/1kPI1… @DFCapodanno @DrKeeble @habib_samady @wfearonmd @MauroEchavPinto @DamienCollison @ColletCarlos @mmamas1973 @profcolinberry
Accuracy of PW–Derived Indices in LMCA Disease @JACCJournals 🔗 authors.elsevier.com/a/1kPI1… ➡️FFR superior to NHPRs at detecting significant LMCA disease ➡️Discordance rates: iFR 18.1% and Pd/Pa 17.0%, primarily due to false negatives @TheBHF @kingscardio @PCRonline @ACCinTouch
3
6
2,191
Grigoris Karamasis retweeted
Really looking forward to TCT. @EssexCTC @MSEResearchTeam lots to learn and discuss. @DrTonyYoung @Craftytracey
8
14
1,708
Grigoris Karamasis retweeted
We hope to have the results of the ORBITA CTO pilot study next year to understand the placebo effect in blinded CTO PCI. @dr_skhan1 @rallamee @Dizzledavies73
The EuroCTO trial showed that PCI provided better symptom relief than OMT after 1 year. Follow-up confirmed sustained angina control, no increased risk of cardiovascular death or non-fatal MI, and lower MACE with successful procedures. In patients with a symptomatic #CTO, PCI can be offered as a safe option to avoid continued antianginal medication. #EIJBestOf ow.ly/We8I50POTFP
3
15
1,297
Grigoris Karamasis retweeted
Kick-starting the new academic year at Attikon Hospital! Let’s dive into recent heart failure trials with highlights from ESC 2024, where RESHAPE-HF2 and FINEARTS-HF were presented, and simultaneously published in NEJM, with our chair and my mentor, @Filippatos playing key roles. 🔹 RESHAPE-HF2: - M-TEER with MitraClip reduced CV death and HF hospitalizations 🏥 by 41% over 24 months - Greater benefits seen in patients with recent HF hospitalizations ⏳ (n=505) 🔹 FINEARTS-HF: - Finerenone in HFpEF (EF ≥40%) reduced worsening HF events and CV death by 18% - Included 6,001 patients with significant quality of life improvements and low hyperkalemia risk 🧪 #HeartFailure #RESHAPEHF2 #FINEARTSHF #ESC2024 #HFAYoung
4
31
2,591
Grigoris Karamasis retweeted
We like to find what we believe. My #cathlab highlights from #CAD 2024 European GL: #radialfirst Class 1A: the end of ‘femoralists”! #FFR Class 1A in intermediate lesions: the end of 1 angio=1 stent! #IVUS/#OCT Class 1A for complex #PCI : the end of ‘I don’t need imaging’ guys!
7
1
67
3,437
Grigoris Karamasis retweeted
Incredibly proud of the @EssexCTC @MSEResearchTeam at EuroPCR. @kliokon & PCR got talent finalist @drR_Simpson. Presentations from @DrS_Fawaz @uxmsajjad. Chaired sessions by @CCook_MD @DrOzanDemir @Dizzledavies73 @dr_skhan1 Incredible team.
1
6
1
36
2,502
Grigoris Karamasis retweeted
Excited for the latest edition of #EuroPCR! Great few days of learning ahead and delighted to be presenting our work from @EssexCTC @MSEHospitals....and it begins! – at Paris, France
2
12
368
Grigoris Karamasis retweeted
Best place for Cath lab based research in the UK. Amazing Cath lab team, research and management support @MSEResearchTeam @MSEssex_ICS @EssexCTC @essexheartfund @MSEHospitals
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
6
1
25
2,524
Grigoris Karamasis retweeted
nhsjobs.com/job/UK/Essex/Bas… We have 2 fully funded interventional MD fellow posts up for grabs starting 2024. Coro physiology / CHIP. Please DM for a chat. @rallamee @MedCrisis @CCook_MD @grkaramasis @NickCurzen @divaka_perera @Ryvetsprog @DrPaulRees @DrNileshPareek @Dizzledavies73
26
1
40
7,997
Grigoris Karamasis retweeted
The best physiology course on the planet. A must attend in 2024 as absolute flow, angio derived indices, live cases and incredible hands on. Can't wait @Dizzledavies73 @rallamee @ColletCarlos @divaka_perera
🔬 Elevate your practice with experts in coronary physiology worldwide! Don't miss out on this exclusive educational experience designed to enhance your skills 🎟️ Only a few seats left: coreaalst.com/physiology @OptimaCTO @CoreAalst @OPCILive
2
10
1,218
Grigoris Karamasis retweeted
Nice to see our study from the mighty Essex Cardiothoracic Centre, UK in your four favourite slides. Thanks!
2
8
375
Grigoris Karamasis retweeted
4/5 (Khan et al. 2023) 3 months after CTO PCI, absolute coronary flow improved (30%), and microvascular resistance decreased (16%). Biggest change was in prior CABG and high eGFR. Smallest change was when extraplaque technique is used (Food for thought!) #CTO2024
1
3
5
844